Mercado mundial de analizadores de química clínica impulsado por mayor volumen de pruebas y TAT más corto por la automatización

Chemistry analyzers are medical laboratory devices used to measure the concentration of particular compounds inside samples of serum, plasma, urine and other body fluids. Substances tested by this equipment include specific metabolites, electrolytes, proteins, and medicines. In today's shifting healthcare environment, laboratories all over the world are under pressure to improve patient care while lowering operating costs. It is one of the most essential aspects of clinical laboratory analysis, and the clinical chemistry analyzer market has made significant progress in recent years. A wide range of tests, including diabetes testing, liver and kidney function, and electrolytes, as well as lipid profiles, thyroid testing, antibiotic drug level monitoring, and other drug level monitoring tests, can now be performed in the physician practice lab using an efficient, state-of-the-art chemistry analyzers.

The global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 and is anticipated to grow at a CAGR of 4.8% over the forecast period (2022-2030). Leading manufacturers in the market are focused on providing a wide range of features such as interactive touch screen interface, advanced optics, on-board curve-fitting software, bichromatic and monochromatic reading, long-lasting IAD filters, and much more. In recent decades, the clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. Thus, these factors are driving the growth of the global clinical chemistry analyzer market. These are the latest findings of Absolute Markets Insights (Pune, India), a market research company.

Based on type, automated clinical chemistry analyzers are gaining huge popularity as automation in clinical chemistry is resulting into higher volume of testing and a shorter turnaround time. When handled by laboratory specialists, the utilization of automated analyzers that can combine a variety of assays, assay types, reagents, software and peripherals provides a holistic package for enhancing clinical efficacy and outcomes. Moreover, automated analyzers improve user safety from biohazards and reduce the possibility of cross-contamination along with providing increased throughput. The leading players in the market are focused on incorporating advanced technologies into their analyzers.

In the last few years, there has been a rise in healthcare awareness among a large population which has led to a rise in clinical testing. The testing of molecular functions is gaining popularity as these tests measure blood sugar, electrolyte, fluid balance, and kidney function which are vital for the early detection of chronic diseases. Moreover, rising concerns over cardiac diseases have also led to increased demand, as these cardiac marker tests measure specific biological markers (biomarkers) in blood to detect various heart diseases. Clinical chemistry analyzers provide high throughput point-of-care solutions for the diagnosis of myocardial infarction and other cardiac-related diseases by measuring the levels of STAT, cardiac troponin, CKM and CKB, myoglobin. Thus, these factors are boosting the demand for clinical chemistry analyzer market globally.

Geographically, Asia Pacific is anticipated to be the fastest growing region in the global clinical chemistry analyzer market over the forecast period. The geriatric population in countries such as China, Japan and India is increasing rapidly, leading to a rise in various age-associated diseases such as hypertension, kidney issues, diabetes, liver problems and others. As these health problems require various tests such as basic metabolic panel, lipid profiles to be carried out, the demand for clinical chemistry analyzers is rising in the Asia Pacific region.

Enlaces relacionados:
Absolute Markets Insights  

Visitar la expo >

Miembro Platino

Analizador de coagulación automatizado

Hemolumi H6

Miembro Oro

Automatic Hematology Analyzer

CF9600

Immunofluorescence Analyzer

IFA System

New

Alzheimer's Disease Biomarker Assay

Elecsys Phospho-Tau (217P) Plasma